Table 1.
CKD Stage 3 | CKD Stage 4 | CKD Stage 5D | |
---|---|---|---|
Phosphorus | Maintain in “normal” range (2C) | Maintain in “normal” range (2C) | Lower towards the normal range (2C) |
Calcium | Maintain in “normal” range (2C) | Maintain in “normal” range (2C) | Maintain in “normal” range (2C) |
Intact PTH | Ideal level unknown | Ideal level unknown | Maintain within >2 and <9x the upper limit of normal (if there is a trend changing within that range, adjust prescription) (2C) |
Note: Grades are given in brackets (number refers to strength of recommendation, where level 1 is strong and level 2 is weak; letter refers to quality of evidence, where A is high, B is moderate, C is low and D is very low).
Based on the KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (Kidney Int 2009;76(suppl 113)).
Abbreviations: PTH, parathyroid hormone; CKD stage 5D, dialysis-dependent chronic kidney disease stage 5; CKD, chronic kidney disease; KDIGO, Kidney Disease: Improving Global Outcomes.